The effect of endurance training on non-alcoholic fatty liver disease in mice.


Journal

Physiological reports
ISSN: 2051-817X
Titre abrégé: Physiol Rep
Pays: United States
ID NLM: 101607800

Informations de publication

Date de publication:
08 2021
Historique:
revised: 21 04 2021
received: 22 03 2021
accepted: 22 04 2021
entrez: 3 8 2021
pubmed: 4 8 2021
medline: 1 3 2022
Statut: ppublish

Résumé

Chronic endurance exercise is a therapeutic strategy in the treatment of non-alcoholic fatty liver disease (NAFLD). Metabolic, cardiorespiratory, and endocrine pathways targeted by chronic endurance exercise have been identified; however, the specific cellular and molecular pathways modified by exercise in the steatotic liver remain unresolved. In this study, we show hepatic gene expression, and the structure, characteristics, and clinical differences between sedentary and exercised mice, by an endurance exercise model with wheels with a controlled velocity that allows for the quantification of a human-relevant endurance "dosage," after exposure to regular and high-fat diet. Chronic exercise modified the transcription of hepatic genes related to liver nuclear receptors, cell growth, fibrosis, inflammation, and oxidative stress, and decreased the amount of lipid accumulation in the liver. Moreover, the combination of endurance training with the change in diet differentially modified the genetic expression of the biomarkers relative to the separate interventions. Even though exercise by itself showed counteract NAFLD development, the combined intervention was sufficient to convert the structure and clinical aspects of the liver from steatotic to healthy. Given our findings, the combination of endurance exercise and change in diet should be considered a therapeutic option for NASH.

Identifiants

pubmed: 34342164
doi: 10.14814/phy2.14926
pmc: PMC8329433
doi:

Substances chimiques

Receptors, Cytoplasmic and Nuclear 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14926

Informations de copyright

© 2021 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.

Références

Hepatology. 2010 Jul;52(1):370-81
pubmed: 20578153
Int J Mol Sci. 2018 Jul 21;19(7):
pubmed: 30037087
Toxicology. 2019 Mar 15;416:1-14
pubmed: 30711707
Hepatology. 2018 Jan;67(1):328-357
pubmed: 28714183
Cytokine. 2012 Aug;59(2):442-9
pubmed: 22658783
World J Gastroenterol. 2014 Nov 14;20(42):15539-48
pubmed: 25400438
Hepatobiliary Pancreat Dis Int. 2015 Apr;14(2):139-44
pubmed: 25865685
J Clin Invest. 2008 Mar;118(3):829-38
pubmed: 18317565
J Clin Invest. 2005 May;115(5):1343-51
pubmed: 15864352
Acta Gastroenterol Belg. 2020 Apr-Jun;83(2):301-307
pubmed: 32603050
Annu Rev Nutr. 2014;34:281-303
pubmed: 24850384
Int J Obes (Lond). 2015 Aug;39(8):1236-40
pubmed: 25835554
Antioxidants (Basel). 2019 Aug 05;8(8):
pubmed: 31387260
Obes Res Clin Pract. 2018 Jan - Feb;12(Suppl 2):80-89
pubmed: 28163011
Am J Physiol Endocrinol Metab. 2006 Jul;291(1):E90-8
pubmed: 16449296
Gene Expr. 2018 Mar 21;18(1):5-17
pubmed: 29096730
Biomed Rep. 2017 Oct;7(4):337-342
pubmed: 29085629
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2010 Aug;26(3):307-11
pubmed: 21038676
World J Gastroenterol. 2016 Aug 7;22(29):6742-56
pubmed: 27547017
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
Int J Exp Pathol. 2006 Feb;87(1):1-16
pubmed: 16436109
Discov Med. 2009 Oct;8(42):151-6
pubmed: 19833064
Curr Hepatol Rep. 2020 Dec;19(4):402-411
pubmed: 33767944
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Dec;1864(12):158519
pubmed: 31473346
PLoS One. 2012;7(10):e46819
pubmed: 23110056
Prog Cardiovasc Dis. 2019 Mar - Apr;62(2):127-134
pubmed: 30796942
Int J Mol Med. 2006 Jan;17(1):45-52
pubmed: 16328010
Diabetes. 2006 Aug;55(8):2159-70
pubmed: 16873678
Hepatology. 2013 May;57(5):1793-805
pubmed: 23299577
Prog Cardiovasc Dis. 2017 Jun - Jul;60(1):67-77
pubmed: 28385556
Mol Metab. 2020 Feb;32:1-14
pubmed: 32029220
Int J Obes (Lond). 2016 Nov;40(11):1760-1767
pubmed: 27216820
BMC Cancer. 2019 Jun 4;19(1):536
pubmed: 31164094
Appl Physiol Nutr Metab. 2010 Apr;35(2):163-71
pubmed: 20383226
Toxicology. 2018 Dec 1;410:199-213
pubmed: 30120929
Hippokratia. 2009 Jan;13(1):9-19
pubmed: 19240815
CMAJ. 2005 Mar 29;172(7):899-905
pubmed: 15795412
J Hepatol. 2018 Sep;69(3):718-735
pubmed: 29777749
Am J Cancer Res. 2019 Jun 01;9(6):1246-1253
pubmed: 31285956
J Sports Sci. 2009 Dec;27(14):1607-15
pubmed: 19967592
Nat Metab. 2020 Apr;2(4):307-317
pubmed: 32601609
J Clin Transl Hepatol. 2020 Jun 28;8(2):120-126
pubmed: 32832391
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Appl Physiol Nutr Metab. 2021 Apr;46(4):356-367
pubmed: 33052711
BMC Endocr Disord. 2009 Jan 28;9:3
pubmed: 19175906
Gene Expr. 2018 May 18;18(2):89-101
pubmed: 29212576

Auteurs

Luma Melo (L)

Laboratory of Investigative Toxicology and Pathology, Department of Environmental and Occupational Health, Indiana School of Public Health, Indiana University, Bloomington, IN, USA.

Merve Bilici (M)

Laboratory of Investigative Toxicology and Pathology, Department of Environmental and Occupational Health, Indiana School of Public Health, Indiana University, Bloomington, IN, USA.

Amit Hagar (A)

History and Philosophy of Science and Medicine Department, Indiana University, Bloomington, IN, USA.
Intelligent Systems Engineering Department, Indiana University, Bloomington, IN, USA.

James E Klaunig (JE)

Laboratory of Investigative Toxicology and Pathology, Department of Environmental and Occupational Health, Indiana School of Public Health, Indiana University, Bloomington, IN, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH